iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer
{{custom_author.name}}, {{article.zuoZheEn}}
iTRAQ-based quantitative analysis of cancer-derived secretory proteome reveals TPM2 as a potential diagnostic biomarker of colorectal cancer
[{{custom_ref.label}}] |
{{custom_citation.content}}
|
/
〈 | 〉 |